https://stock.noler.com/us/stock/pandion-therapeutics-inc https://stock.noler.com/us/stock/pandion-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/pandion-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/pandion-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/pandion-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/pandion-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/pandion-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/pandion-therapeutics-inc/allowance-for-doubtful-accounts-receivable-recoveries https://stock.noler.com/us/stock/pandion-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/pandion-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/pandion-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/pandion-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/pandion-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/pandion-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/pandion-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/pandion-therapeutics-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/pandion-therapeutics-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/pandion-therapeutics-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/pandion-therapeutics-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/pandion-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/pandion-therapeutics-inc/current-assets https://stock.noler.com/us/stock/pandion-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/pandion-therapeutics-inc/debt-issued https://stock.noler.com/us/stock/pandion-therapeutics-inc/debt-repaid https://stock.noler.com/us/stock/pandion-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/pandion-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/pandion-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/pandion-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/pandion-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/pandion-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/pandion-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/pandion-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-deferred-rent https://stock.noler.com/us/stock/pandion-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/pandion-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/pandion-therapeutics-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/pandion-therapeutics-inc/depreciation https://stock.noler.com/us/stock/pandion-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/pandion-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/pandion-therapeutics-inc/estimate-of-possible-loss https://stock.noler.com/us/stock/pandion-therapeutics-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/pandion-therapeutics-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/pandion-therapeutics-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/pandion-therapeutics-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/pandion-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/pandion-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/pandion-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/pandion-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/pandion-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/pandion-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/pandion-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/pandion-therapeutics-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/pandion-therapeutics-inc/income-tax https://stock.noler.com/us/stock/pandion-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/pandion-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/pandion-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/pandion-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/pandion-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/pandion-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/pandion-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/pandion-therapeutics-inc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/pandion-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/pandion-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/pandion-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/pandion-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/pandion-therapeutics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/pandion-therapeutics-inc/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/pandion-therapeutics-inc/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/pandion-therapeutics-inc/level-3-liability-change https://stock.noler.com/us/stock/pandion-therapeutics-inc/level-3-liability-settlements https://stock.noler.com/us/stock/pandion-therapeutics-inc/members-equity https://stock.noler.com/us/stock/pandion-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/pandion-therapeutics-inc/net-income https://stock.noler.com/us/stock/pandion-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/pandion-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/pandion-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/pandion-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/pandion-therapeutics-inc/operating-income https://stock.noler.com/us/stock/pandion-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/pandion-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/pandion-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/pandion-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/pandion-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/pandion-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/pandion-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/pandion-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/pandion-therapeutics-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/pandion-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/pandion-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/pandion-therapeutics-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/pandion-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/pandion-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/pandion-therapeutics-inc/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/pandion-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/pandion-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/pandion-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/pandion-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/pandion-therapeutics-inc/prepaid-insurance https://stock.noler.com/us/stock/pandion-therapeutics-inc/prepaid-taxes https://stock.noler.com/us/stock/pandion-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/pandion-therapeutics-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/pandion-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/pandion-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/pandion-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/pandion-therapeutics-inc/public-float https://stock.noler.com/us/stock/pandion-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/pandion-therapeutics-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/pandion-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/pandion-therapeutics-inc/revenue https://stock.noler.com/us/stock/pandion-therapeutics-inc/secured-long-term-debt https://stock.noler.com/us/stock/pandion-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/pandion-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/pandion-therapeutics-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/pandion-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/pandion-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/pandion-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/pandion-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/pandion-therapeutics-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/pandion-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/pandion-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/pandion-therapeutics-inc/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/pandion-therapeutics-inc/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/pandion-therapeutics-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/pandion-therapeutics-inc/temporary-equity-elimination-as-partof-reorganization https://stock.noler.com/us/stock/pandion-therapeutics-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/pandion-therapeutics-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/pandion-therapeutics-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/pandion-therapeutics-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/pandion-therapeutics-inc/temporary-equity-shares-issued-value-new-issues https://stock.noler.com/us/stock/pandion-therapeutics-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/pandion-therapeutics-inc/total-assets https://stock.noler.com/us/stock/pandion-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/pandion-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/pandion-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/pandion-therapeutics-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/pandion-therapeutics-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/pandion-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/pandion-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted